Evkeeza Market 2026 expanding with rare lipid disorder treatments

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Evkeeza Market During The Forecast Period 2026–2030?

The growth observed in the historical period was primarily due to the limited efficacy of conventional statins, the enduring burden of familial hypercholesterolemia, the advent of early biologic lipid therapies, the persistent unmet needs among HoFH patients, and the increased adoption of treatments spearheaded by specialists.

The anticipated expansion during the forecast period is attributed to factors like heightened genetic screening for lipid disorders, an increase in the adoption of biologics, broader reimbursement provisions for rare diseases, advancements in lipid metabolism research, and the proliferation of specialty cardiology centers. Significant trends projected for this period involve the wider application of monoclonal antibody therapies, a growing emphasis on uncommon lipid disorders, the development of more precise lipid-lowering treatments, increased utilization of targeted ANGPTL3 inhibitors, and better patient outcomes for severe hypercholesterolemia.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20070&type=smp

Which Economic Or Industry Drivers Are Impacting The Evkeeza Market?

The evkeeza market is expected to expand moving forward due to the rising occurrence of genetic disorders. These conditions stem from DNA irregularities, such as gene mutations or chromosomal alterations. The increase in genetic disorders can be attributed to better diagnostic tools and a greater influence of environmental factors on genetic conditions. Evkeeza addresses homozygous familial hypercholesterolemia (HoFH), a genetic ailment, by blocking ANGPTL3 to reduce LDL cholesterol in affected patients. For example, the American Society of Hematology, a US-based non-profit organization, reported in June 2024 that the worldwide population of those with sickle cell disease (SCD) is predicted to increase by roughly 30 percent by 2050. Consequently, the growing incidence of genetic disorders is boosting the evkeeza market’s growth.

Evkeeza Market Driver: Impact Of Increasing Drug Approvals On The Growth Of The Evkeeza Market

The evkeeza market is poised for growth in the upcoming years, driven by a rising count of drug approvals. Drug approvals signify the official procedure where regulatory bodies assess and permit pharmaceutical drugs for public use. The surge in drug approvals is primarily linked to biotechnological progress that accelerates drug discovery, alongside encouraging regulatory structures such as accelerated approval programs that streamline the process for essential medications. Drug approvals propel evkeeza’s market by enhancing its accessibility for treating homozygous familial hypercholesterolemia, improving patient reach, and capitalizing on benefits like orphan drug exclusivity. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, noted that in 2023, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, a significant jump from the six approvals in 2022. Thus, the increasing rate of drug approvals is fueling the expansion of the evkeeza market.

What Market Segments Are Evaluated Within The Evkeeza Market?

The evkeeza market covered in this report is segmented –

1) By Indication: Primary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia

2) By Route Of Administration: Intravenous (IV) Infusion, Self-Administration, Subcutaneous (SC) Administration, Hospital Infusion Centers, Infusion In Ambulatory Care Settings

3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

What Industry Trends Are Redefining The Evkeeza Market?

A significant trend in the evkeeza market centers on securing regulatory approvals for drugs to broaden their accessibility and strengthen their presence in treating patients with homozygous familial hypercholesterolemia (HoFH). Regulatory approvals signify the formal permission granted by governmental or official bodies, allowing a drug, medical device, or treatment to be commercialized and used by the public. For instance, in March 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, received FDA approval for Evkeeza (evinacumab-dgnb) specifically for young children aged 5 to 11 years who have homozygous familial hypercholesterolemia (HoFH), a rare genetic condition characterized by extremely high LDL cholesterol levels. This marks the inaugural approval of an ANGPTL3 inhibitor for this age group, providing a new treatment option for approximately 1,300 affected individuals in the U.S. Clinical trials revealed that children administered evkeeza alongside other lipid-lowering therapies experienced an average 48% reduction in LDL-C levels after 24 weeks.

Who Are The Top Market Participants Influencing The Evkeeza Market?

Major companies operating in the evkeeza market are Regeneron Pharmaceuticals Inc.

Read the full evkeeza market report here:

https://www.thebusinessresearchcompany.com/report/evkeeza-global-market-report

What Are The Top-Performing Regions Within The Evkeeza Market?

North America was the largest region in the evkeeza market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the evkeeza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Evkeeza Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20070&type=smp

Browse Through More Reports Similar to the Global Evkeeza Market 2026, By The Business Research Company

Evtol Aircraft Market 2026

https://www.thebusinessresearchcompany.com/report/evtol-aircraft-market

Luxury Electric Vehicles Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-electric-vehicles-global-market-report

Ev Tires Market Report 2026

https://www.thebusinessresearchcompany.com/report/ev-tires-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795